These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8831039)

  • 1. Disk diffusion interpretive criteria for fusidic acid susceptibility testing of staphylococci by the National Committee for Clinical Laboratory Standards method.
    Coutant C; Olden D; Bell J; Turnidge JD
    Diagn Microbiol Infect Dis; 1996 May; 25(1):9-13. PubMed ID: 8831039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of MIC methods and tentative interpretive criteria for disk diffusion susceptibility testing using NCCLS methodology for fusidic acid.
    Skov R; Frimodt-Møller N; Espersen F
    Diagn Microbiol Infect Dis; 2001 Jul; 40(3):111-6. PubMed ID: 11502378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial activity of fusidic acid and disk diffusion susceptibility testing criteria for gram-positive cocci.
    Toma E; Barriault D
    J Clin Microbiol; 1995 Jul; 33(7):1712-5. PubMed ID: 7665633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of fusidic acid and mupirocin against coagulase-positive staphylococci from pets.
    Loeffler A; Baines SJ; Toleman MS; Felmingham D; Milsom SK; Edwards EA; Lloyd DH
    J Antimicrob Chemother; 2008 Dec; 62(6):1301-4. PubMed ID: 18819974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility in vitro of canine methicillin-resistant and -susceptible staphylococcal isolates to fusidic acid, chlorhexidine and miconazole: opportunities for topical therapy of canine superficial pyoderma.
    Clark SM; Loeffler A; Bond R
    J Antimicrob Chemother; 2015 Jul; 70(7):2048-52. PubMed ID: 25749003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence and molecular characterization of fusidic acid resistance mechanisms among Staphylococcus spp. from European countries (2008).
    Castanheira M; Watters AA; Mendes RE; Farrell DJ; Jones RN
    J Antimicrob Chemother; 2010 Jul; 65(7):1353-8. PubMed ID: 20430787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial activity of coumermycin and recommendations for disk diffusion tests with 5- and 15-micrograms disks.
    Jones RN; Barry AL
    Diagn Microbiol Infect Dis; 1987 May; 7(1):77-82. PubMed ID: 3691036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calibration of fusidic acid disk diffusion susceptibility testing of Staphylococcus areus.
    Olsson-Liljequist B; Kõljalg S; Karlsson I; Kronvall G
    APMIS; 2002 Oct; 110(10):690-6. PubMed ID: 12583435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of fusidic acid (CEM-102) susceptibility testing reagents: broth microdilution, disk diffusion, and Etest methods as applied to Staphylococcus aureus.
    Jones RN; Castanheira M; Rhomberg PR; Woosley LN; Pfaller MA
    J Clin Microbiol; 2010 Mar; 48(3):972-6. PubMed ID: 20053856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibility of methicillin-resistant Staphylococcus aureus and slime-producing and non-slime-producing coagulase-negative staphylococci to fusidic acid.
    Huebner J; Kropec A; Engels I; Daschner F
    Chemotherapy; 1992; 38(4):206-10. PubMed ID: 1473358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of interpretive criteria and quality control limits for macrolide and clindamycin susceptibility testing of Streptococcus pneumoniae.
    Jorgensen JH; Swenson JM; Tenover FC; Barry A; Ferraro MJ; Murray PR; Reller LB
    J Clin Microbiol; 1996 Nov; 34(11):2679-84. PubMed ID: 8897164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MIC determination of fusidic acid and of ciprofloxacin using multidisk diffusion tests.
    Kronvall G
    Clin Microbiol Infect; 2000 Sep; 6(9):483-9. PubMed ID: 11168182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissemination of fusidic acid resistance among Staphylococcus aureus clinical isolates.
    Yu F; Liu Y; Lu C; Lv J; Qi X; Ding Y; Li D; Huang X; Hu L; Wang L
    BMC Microbiol; 2015 Oct; 15():210. PubMed ID: 26463589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Epsilometer test (E test) for testing the susceptibility of coagulase-negative staphylococci to teicoplanin.
    Martin E; Nouvellon M; Pestel M; Pons JL; Lemeland JF
    J Antimicrob Chemother; 1995 Jul; 36(1):83-91. PubMed ID: 8537287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staphylococcus aureus and coagulase-negative staphylococci from blood stream infections: frequency of occurrence, antimicrobial susceptibility, and molecular (mecA) characterization of oxacillin resistance in the SCOPE program.
    Marshall SA; Wilke WW; Pfaller MA; Jones RN
    Diagn Microbiol Infect Dis; 1998 Mar; 30(3):205-14. PubMed ID: 9572028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of Staphylococcus aureus to fusidic acid: Canadian data.
    Rennie RP
    J Cutan Med Surg; 2006; 10(6):277-80. PubMed ID: 17241597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility of bovine mastitis pathogens to a combination of penicillin and framycetin: development of interpretive criteria for testing by broth microdilution and disk diffusion.
    Pillar CM; Stoneburner A; Shinabarger DL; Abbeloos E; Goby L; Bradley AJ
    J Dairy Sci; 2014 Oct; 97(10):6594-607. PubMed ID: 25129497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the activity of fusidic acid tested against contemporary Gram-positive clinical isolates from the USA and Canada.
    Pfaller MA; Castanheira M; Sader HS; Jones RN
    Int J Antimicrob Agents; 2010 Mar; 35(3):282-7. PubMed ID: 20036520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel fusidic acid resistance determinant, fusF, in Staphylococcus cohnii.
    Chen HJ; Hung WC; Lin YT; Tsai JC; Chiu HC; Hsueh PR; Teng LJ
    J Antimicrob Chemother; 2015 Feb; 70(2):416-9. PubMed ID: 25313205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Staphylococcus aureus and coagulase-negative staphylococci with decreased sensitivity to glycopeptides as assessed by determination of MICs.
    Vedel G; Leruez M; Lémann F; Hraoui E; Ratovohery D
    Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):820-2. PubMed ID: 2150815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.